Review of the single and multiple technology appraisal processes
Introduction and Background
The Institute has undertaken a review of the Guides to the Single and Multiple Technology Appraisal Processes. These guides contain information on how technology appraisals are conducted.
NICE had originally planned to publish updated guides on the Single and Multiple Technology Appraisal Processes in June 2009. However, the arrangements within the 2009 Pharmaceutical Price Regulation Scheme (PPRS) agreement has required a further update to the process guides.
We feel it is important that our stakeholders are able to comment on this, and are therefore consulting for one month.
A new section five of both guides has been included to cover the requirements of the 2009 PPRS agreement, and is now open for consultation (see links below). The version we are consulting on is tailored specifically for the STA Process Guide. The MTA version is the same in content with just the relevant references altered.
We would like to receive comments on this section from anyone who has an interest in the Technology Appraisal Programme.
Thank you very much for your comments on the consultation that ended in March. We are very grateful for your comments and are looking at them now. This update is an extra addition to the guides that went out for consultation in December; we have not made any changes from the consultation in December so you do not need to worry about resending your comments on the original consultation.
At the close of this additional consultation we will consider the comments alongside the comments already received (from the consultation that ended in March 2009) and amend the process guide accordingly. We will produce the final draft of the updated guides and anticipate they will be reviewed by the Board in September 2009.
NB: This is not the Institute's formal process guide. This section is a draft and may change following this public consultation. Until the updated guides are published, the existing versions must be followed for all ongoing appraisals.
Consultation period: Friday 19 June to Monday 20 July 2009
How to submit your comments:
1. Use the form below for commenting on section five.
2. Fill in your name, the organisation you represent and your role at that organisation (if applicable).
3. Fill in the paragraph number that your comment relates to (for example 5.1).
4. Please put each separate comment on a new row on the comment form.
5. Email your completed comments form to firstname.lastname@example.org by 5pm on Monday 20 July 2009.
NICE is committed to promoting equality and eliminating unlawful discrimination. If you have a disability which prevents you from submitting your comments, please contact general enquires at email@example.com or call us on 0845 003 7781 to arrange an alternative way to comment.
The Institute is unable to accept:
- Comments received after the consultation deadline (5pm on Monday 20 July 2009).
- Comments that are not submitted using the comment form (unless alternative arrangements have been made).
- Confidential information or other material that you would not wish to be made public.
- Attachments such as journal articles. If you wish to highlight specific studies please cite the full journal reference in your comments.
Acknowledgement of comments:
Although we do not reply to comments on an individual basis, you should receive an automated acknowledgement when you submit your comments. If you do not receive this acknowledgement, please contact general enquires at firstname.lastname@example.org or call 0845 003 7781 to ensure your comments have been received.
The Institute has also launched a public consultation on the patient access scheme submission template for technology appraisals. If manufacturers and sponsors wish to submit a patient access scheme to the appraisals programme of the National Institute of Health and Clinical Excellence (NICE) they should do so using this template. The template contains the information NICE requires for the assessment of the impact of patient access schemes on clinical and cost effectiveness in the context of a technology appraisal, and explains the way in which evidence should be presented.
Links to section five, comment form and supporting documentation:
- Section 5 - Patient Access and Flexible Pricing Schemes
- Comments form
- Consultation on ‘Patient access scheme submission template´
Please find below the MTA & STA Technology Appraisal Guides that went out for public consultation in December 2008. These are for information only; please do not submit comments on these guides.
- Updated guide to the multiple technology appraisal process
- Updated guide to the single technology appraisal process
This page was last updated: 18 June 2009